Inhibikase Therapeutics (IKT) Return on Sales Growth (3y) (2023 - 2024)
Inhibikase Therapeutics (IKT) Return on Sales Growth (3y) (2023 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROS Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
5.00 |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
0.00 |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Inhibikase Therapeutics |
285.17 Mn |
114.80 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2024 |
-20.06 Mn |
| Jun 30, 2024 |
-237.00 |
| Mar 31, 2024 |
-101.00 |
| Dec 31, 2023 |
-4.40 Mn |
| Sep 30, 2023 |
-42.00 |
| Jun 30, 2023 |
-51.00 |
| Mar 31, 2023 |
-71.00 |
